Getting a taste of study at EIT’s Taster Days

Source: Eastern Institute of Technology – Tairāwhiti

  • Home
  • News
  • Getting a taste of study at EIT’s Taster Days

55 seconds ago

Capri Whioke Kete, Te Kura Kaupapa Māori o Te Ara Hou student, attended an arts workshop at IDEAschool.

Young people from all over Hawke’s Bay recently got a taste of what studying at EIT might look like for them.

Over the last three days, EIT hosted its biannual taster days for high school students and young people between 15 and 18 years.

This year, 192 people registered for the courses, more than ever before.

The students could choose between 13 different workshops, ranging from business, sport science or environmental management to vet nursing, arts and design or wine science.

The courses are designed to give prospective students an insight into studying a particular subject and familiarise them with the campus and its facilities.

School students also get the opportunity to find out which qualification may most suit their interests, talents and abilities and get first-hand information from lecturers and tutors

SH2 eastbound lane blocked at Paengaroa

Source: New Zealand Transport Agency


Waka Kotahi NZ Transport Agency advises the eastbound lane of State Highway 2 is blocked at the intersection with Wilson Road North at Paengaroa, where a truck has overturned.

Motorists are asked to avoid the area, delay unnecessary travel or consider alternate routes where possible, and to follow the directions of emergency services or traffic management staff on site.

Visit Waka Kotahi’s Journey Planner website ( link)) for up to date information on up to date information on road or lane closures, detours, road works, traffic and delays.

Waka Kotahi thanks motorists for their patience.

Plan ahead for a safe, enjoyable journey. Keep up to date with:

Syndicate for Launch of 15 May 2041 Nominal Bond Announced

Source: New Zealand Treasury:

The information on this website is issued by New Zealand Debt Management for informational purposes. To the extent that this website refers to an offer of securities, no offer is made to anyone accessing this website outside of New Zealand and otherwise than in compliance with any applicable securities laws or regulations.

Nominal Bonds, Inflation-Indexed Bonds and Treasury Bills: Wholesale domestic government debt securities, including nominal bonds, inflation-indexed bonds and Treasury bills (together, “Government Securities”) cannot be purchased directly from New Zealand Debt Management by individuals. Only registered tender counterparties who participate in a Government Securities tender process are able to purchase Government Securities from New Zealand Debt Management. Any offer documents provided or contained on this website relating to Government Securities contain an offer to registered tender counterparties only.

Where Government Securities are offered on the secondary market to any person in any jurisdiction, such Government Securities are not offered, and must not be bought or sold, except under circumstances that will result in compliance with any applicable securities laws or regulations.

Kiwi Bonds: Only people who are New Zealand residents can purchase Kiwi Bonds from New Zealand Debt Management. No offer of Kiwi Bonds is made to anyone who is not a New Zealand resident. For the avoidance of doubt, this means anyone resident outside New Zealand, even if they hold New Zealand citizenship, is ineligible to purchase Kiwi Bonds from New Zealand Debt Management. No offer of Kiwi Bonds from New Zealand Debt Management is made to any person who holds New Zealand citizenship but is resident outside New Zealand.

Users accessing this website from outside New Zealand acknowledge and accept that they will comply with any applicable securities laws or regulations.

Dunedin to Port Chalmers – build in extra time from next week as shared path project progresses

Source: New Zealand Transport Agency

People who use the highway between Dunedin and Port Chalmers, SH88, should plan for short delays – a few minutes extra to the overall journey – from this coming Monday, 13 July.

The work in the Roseneath cutting area is part of Waka Kotahi NZ Transport Agency’s safety improvements project and shared cycle path on this section of highway.

“This particular piece of work will take around nine weeks through to September,” says Jason Forbes, Senior Project Manager, Waka Kotahi.

Waka Kotahi Senior Project Manager Jason Forbes at St Leonards at the start of the final section of the West Harbour cycleway extension through to Port Chalmers in May this year. (Photo courtesy The Star(external link))

 “We need to build a 200-metre long steel and concrete retaining wall that will carry the St Leonards to Port Chalmers section of the shared path through the Roseneath cutting. The highway will be reduced to one lane and controlled by traffic lights while this retaining wall construction is underway.

“People should be aware also that the single lane with traffic lights will be in place 24 hours a day for significant parts of this construction. But wherever we can do so safely, we will open both lanes to help minimise delays.”

  • The retaining wall will be built in two stages, says Mr Forbes, with the first stage, taking around nine weeks, starting Monday with the installation of steel piles.
  • Later in the year, concrete panels will be fitted to the retaining wall and material fill placed behind the panels.  

Curles Point work from Monday for three to four weeks

Work also starts from Monday 13 July at Curles Point between St Leonards and Roseneath. This involves accessing the rail line and installing rock walls to strengthen this part of the rail corridor to carry a section of the new shared path between St Leonards and Port Chalmers. This work is expected to take up to four weeks, subject to weather.

“For safety reasons, it’s necessary to close the majority of the Curles Point area, but wherever possible public access will be retained to part of the area,” says Mr Forbes.

For background on the shared path and safety improvements planned for this highway: (external link)

Plan ahead for a safe, enjoyable journey. Keep up to date with:

Cabinet Paper LEG-20-SUB-0066: Overseas Investment Amendment Regulations 2020

Source: New Zealand Treasury:

Accessible HTML version

Only the Proposal and Policy sections of this Cabinet paper are extracted below in HTML. If you require a full HTML version please contact and cite Cabinet Paper LEG-20-SUB-0066: Overseas Investment Amendment Regulations 2020 as a reference.

Cabinet Paper LEG-20-SUB-0066: Overseas Investment Amendment Regulations 2020 


  1. This paper seeks authorisation for submission to the Executive Council of the Overseas Investment Amendment Regulations 2020 (‘the Essential Amendment Regulations’), which amend the Overseas Investment Regulations 2005 (‘the Regulations’).
  2. The Essential Amendment Regulations can be made pursuant to sections 61, 61C and new section 127 of the Overseas Investment Act 2005 (‘the Act’).


  1. The Essential Amendment Regulations will implement policy decisions made by Cabinet on 11 May 2020 [CAB-20-MIN-0212 refers], and one additional decision made under delegated authority regarding the Act’s treatment of loans.
  2. Changes to the Regulations are required to operationalise changes to the Act in the Overseas Investment (Urgent Measures) Amendment Bill 2020 (‘Urgent Measures Bill’). The Urgent Measures Bill is an urgent priority.

Extract ends

Decision to list medical devices supplied by Baxter Healthcare Limited

Source: Pharmac

What we’re doing

We are pleased to announce the approval of a listing agreement with Baxter Healthcare Limited (“Baxter”) for the supply of haemodialysis equipment and products to DHBs.

In summary this will result in:

  • Baxter’s products being listed in Part III of Section H of the Pharmaceutical Schedule from 1 August 2020 under a national agreement that all DHBs may purchase under (“Agreement”); and
  • DHBs being able to continue to purchase other suppliers’ brands of haemodialysis equipment and products.

Any changes to the original proposal?

This decision was subject to a consultation letter dated 12 February 2020 and then a second round of consultation with DHB stakeholders which was released on 5 June 2020.

Missing products were added to the listing, conditions around installation of equipment and tools for commercial calculations were updated in response to feedback from our first round of consultation.

Only minor amendments have been made to the commercial tools following the second round of consultation.

Who we think will be most interested

  • DHB staff:
    • Haemodialysis staff
    • Procurement managers
  • Suppliers and wholesalers

Details about this decision

In February 2018, PHARMAC issued a Request for Proposal (“RFP”) for haemodialysis products for non-exclusive national agreements for listing on the Pharmaceutical Schedule.

After completing the RFP evaluation processes, and consulting on the provisional Agreement reached with Baxter, PHARMAC has decided to list Baxter’s medical devices in Part III of Section H of the Pharmaceutical Schedule from 1 August 2020.

The list of products will be available of PHARMAC’s website from 1 August 2020, in both a PDF document and an Excel spreadsheet.

DHBs can continue to choose which haemodialysis products they purchase, including those from other suppliers. DHBs that purchase haemodialysis products from Baxter must do so under the terms and conditions, including pricing, in the Agreement, from 1 August 2020.

The Agreement includes terms and conditions for training and education to be provided by Baxter on the appropriate use of its products, which is to be provided at times as agreed with individual DHBs.

Our response to what you told us

We appreciate the time people took to respond to this consultation.

A summary of the main themes raised in feedback and our responses to the feedback are set out below:



Products currently purchased from supplier were missing from the proposed device listings.

These products have now been included and updated. 

Commercial calculation tool does not allow for all products and support to be included.

The tools have been updated in both products and format to allow greater flexibility.

The commercial tools used are a useful addition.


If you have any questions about this decision, you can email us at; or call our toll free number (9 am to 5 pm, Monday to Friday) on 0800 66 00 50.

Last updated: 8 July 2020

FMA publishes Statement of Intent and Statement of Performance Expectations

Source: Financial Markets Authority

Media Release
MR No. 2020 – 23
30 June 2020

The Financial Markets Authority (FMA) has today released two documents that together set out how the regulator will measure and report on progress against its performance measures and targets.

The Statement of Intent 2020-2024 (SOI) explains how the FMA will measure progress towards achieving its medium-term strategic intentions, while the Statement of Performance Expectations 2020/21 (SPE) sets out annual non-financial performance measures and financial forecast.

The reports should be read together to understand the FMA’s performance measures and reporting framework.


Media contacts:

Andrew Park
FMA Media Relations Manager
021 220 6770

Campbell Gibson
FMA Senior Adviser, Media Relations
021 945 323

Proposal to list medical devices supplied by Lohmann & Rauscher Limited

Source: Pharmac

What we’re proposing

PHARMAC is seeking feedback on a proposal to list medical devices supplied by Lohmann & Rauscher Limited (“Lohmann & Rauscher”) in Part III of Section H of the Pharmaceutical Schedule from 1 September 2020.

We propose to list medical devices in the following categories:

  • rehabilitation equipment, patient positioning products and supports (“rehabilitation products”); and
  • non-dedicated and consumable infusion devices.

Consultation closes at 5pm Thursday 30 July 2020 and feedback can be emailed to

What would the effect be?

From 1 September 2020, rehabilitation products and non-dedicated and consumable infusion devices, supplied by Lohmann & Rauscher, would be listed under a proposed national agreement for all DHB hospitals to purchase under, subject to consultation and approval by PHARMAC’s Board or delegate (“Agreement”).

The Agreement would not be for sole supply and DHBs could continue to purchase other suppliers’ brands of products in these categories of devices.

The Agreement would supersede any existing DHB contracts with Lohmann & Rauscher for the products included in the Agreement. Any product listed in the Agreement and purchased by a DHB would be in accordance with the terms and conditions, including price, stated in the Agreement effective from the date of listing on the Pharmaceutical Schedule.

Lohmann & Rauscher would provide appropriate educational services that would be tailored to the individual needs of DHBs, in formats and at times as required by DHBs.

Pricing for the devices in this Agreement, subject to any prior termination of the Agreement, would not be increased without prior consultation and approval by PHARMAC.

Who we think will be interested

  • DHB clinical staff in a range of different clinical settings inluding:
    • Ambulatory care
    • Perioperative care
    • Surgical and General Medical care
    • Intensive care
    • Clinical engineering and maintenance services
    • Infection control
    • Occupational health and safety
    • Anaesthetists
    • Rehabilitation physicians (including spinal units)
    • Allied Health staff
    • Nurses
  • DHB procurement and supply chain personnel
  • Suppliers and wholesalers

About the medical devices

Rehabilitation products

Rehabilitation is the process of regaining strength or relearning skills after a serious injury, illness or surgery. Rehabilitation crosses all age groups, though the type, level and goals of rehabilitation will differ depending on the individual needs. Rehabilitation often focuses on:

  • physical therapy to help with strength, mobility and fitness;
  • occupational therapy to help with daily activities;
  • speech-language therapy to help with speaking, understanding, reading, writing and swallowing;
  • cognitive therapy (following head injury); and
  • treatment of pain.

Infusion devices

Infusion devices are medical devices used, or associated with devices used, in the infusion of fluids such as medications, intravenous solutions (such as saline, glucose, and electrolyte solutions), blood, total parenteral nutrition (TPN) solutions into the body. This includes medical devices used in intravenous therapy as well as other infusion therapies.

PHARMAC’s infusion devices category includes:

Why we’re proposing this

In 2018 PHARMAC issued Requests for Proposals for:

The RFPs were for non-exclusive national agreements for listing on the Pharmaceutical Schedule.

PHARMAC has been working with suppliers who responded to the RFPs, and proposals were progressed to contract negotiation to seek provisional agreements. These proposals are the latest to arise from this process and we expect to consult on further provisional agreements with suppliers of rehabilitation products, and non-dedicated and consumable infusion devices throughout 2020.

Details about our proposal

The proposal would result in listing 11 products in the Pharmaceutical Schedule from Lohmann & Rauscher.



Line items

Rehabilitation products

  • Cellona Shoe


Non-dedicated and consumable infusion devices

  • Curafix i.v
  • Curagard


Further information, including pricing and contractual details, has been provided to DHB Procurement personnel. Clinicians interested in further detail on what this change means for their DHB should engage with their Procurement teams.

To provide feedback

Send us an email: by 5pm Thursday 30 July 2020.

All feedback received before the closing date will be considered by PHARMAC’s Board (or its delegate) prior to making a decision on this proposal.

Feedback we receive is subject to the Official Information Act 1982 (OIA) and we will consider any request to have information withheld in accordance with our obligations under the OIA. Anyone providing feedback, whether on their own account or on behalf of an organisation, and whether in a personal or professional capacity, should be aware that the content of their feedback and their identity may need to be disclosed in response to an OIA request.

We are not able to treat any part of your feedback as confidential unless you specifically request that we do, and then only to the extent permissible under the OIA and other relevant laws and requirements. If you would like us to withhold any commercially sensitive, confidential proprietary, or personal information included in your submission, please clearly state this in your submission and identify the relevant sections of your submission that you would like it withheld. PHARMAC will give due consideration to any such request.

Last updated: 8 July 2020

Snow forecast for Desert Road tomorrow, motorists take care

Source: New Zealand Transport Agency

Waka Kotahi NZ Transport Agency is encouraging motorists to expect winter driving conditions on the Desert Road tomorrow.

Waikato System Manager Cara Lauder says the Metservice is forecasting significant amounts of snow for the Desert Road between 2pm and 10pm tomorrow (Wednesday 8 July) and with additional traffic on the roads due to the school holidays and the opening of the Whakapapa ski field (the Tūroa ski field is scheduled to open Saturday 11 July) on Mt Ruapehu, motorists are asked to take care.

“We encourage drivers to be prepared for icy conditions and snow. Road closures are likely.

“Plan ahead and allow extra time for your journeys and drive to the road and weather conditions. Maintain a greater following distance between your vehicle and the one in front, and slow down and be prepared for unexpected hazards.”

State Highways 4, 46, 47 and 49, as well as State Highway 5 between Napier and Taupō, and the Napier-Taihape Road may also be affected by snow and ice.

Ms Lauder says motorists can prepare by ensuring their vehicles are safe, roadworthy and well-equipped for winter driving.

“Make sure you have a safe spare tyre, your lights, brakes and windscreen-wipers are all working, and you have a clean windscreen inside and out. Ensure your mobile phone is well charged and carry a car phone charger or power bank. Blankets, snacks and bottles of water are also a good idea, in case of an emergency or breakdown.”

Visit the Journey Planner website(external link) for up to date information on road closures, detours, road works, traffic and delays.

Winter driving tips

  • Check link) for weather and travel conditions on highways before you start your trip and on breaks throughout your journey or call 0800 4 HIGHWAYS (0800 44 44 49).
  • Ensure your car is safe and well-equipped: spare tyre, warrant of fitness is up-to-date, lights, brakes and wind-wipers all working, clean windscreen inside and out, check tyre treads to ensure good grip.
  • If you are travelling long distances, share the driving and have regular breaks.
  • Wear your seat belt throughout the journey and check your passengers have theirs clicked in too.
  • Driving on roads that are exposed to snow and ice can be treacherous, so slow down and drive to the conditions, not the allowable/legal speed limit. Increase the following distance between you and the vehicle ahead.
  • Be prepared when travelling in case of delays on the road, particularly in alpine conditions. Make sure you have warm clothes/food/water/charged mobile phone. In an emergency, phone 111. Bear in mind some parts of the highway have no mobile phone coverage.
  • Learn about winter driving, including how to get your vehicle ready and if you are driving in an area where chains may be needed, practise putting them on before you go so you are not caught out.

More winter driving tips and advice

Plan ahead for a safe, enjoyable journey. Keep up to date with:

Locals gain from removal of unsafe trees

Source: Department of Conservation


The removal of unsafe exotic trees in Egmont National Park will have flow on benefits to the Taranaki community, says the Department of Conservation.

Date:  07 July 2020

More than 100 eucalyptus trees near the entrance to Lucy’s Gully in the Kaitake Ranges have been removed by logging contractors through June and July.

The large trees had become hazardous, with trees and branches regularly falling onto the access road, fences and neighbouring properties, says DOC Taranaki Senior Ranger Dave Rogers.

“The trees were planted as part of an employment scheme during the Depression in the 1930s before the Kaitake Range was integrated into the National Park,” he says.

The tree removal is part of the Egmont National Park Management Plan, and is planned to be completed over coming weeks, weather permitting. Additional funding has been secured to expand the work and remove a further 40 eucalyptus trees.

All work on removal of the trees is being undertaken by local Taranaki businesses, with the safety overseer, logging contractors,  traffic management team, haulage company, earth movers and roading team all coming from the region.

Any proceeds gained from the sale of the timber will help offset the costs of the tree removal.

A local forestry school will use the wood debris from the site for chainsaw training. A proposal to distribute the resulting firewood as part of a DOC/COVID-19 initiative to support whānau and hapū and others in the community facing hardship is currently been investigated.

“The planting of these trees back during the Depression of the 1930s helped support local Taranaki people and we wanted to ensure local businesses benefit from their removal,” says DOC Taranaki Operations Manager Gareth Hopkins.

For safety reasons, access to Lucy’s Gully has been restricted from time to time while the work has been underway. Members of the public are urged to stay clear of the work site while the felling is undertaken.

DOC is looking at options to support native species regeneration at the site with additional planting and weed control.


For media enquiries contact:

Phone: +64 4 496 1911